[Bosentan: a considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases]. [electronic resource]
Producer: 20140818Description: 32-9 p. digitalISSN:- 0040-3660
- Antihypertensive Agents -- administration & dosage
- Bosentan
- Chemical and Drug Induced Liver Injury -- diagnosis
- Disease Progression
- Dose-Response Relationship, Drug
- Drug Monitoring
- Drug Therapy, Combination
- Endothelin Receptor Antagonists
- Female
- Humans
- Hypertension, Pulmonary -- diagnosis
- Kaplan-Meier Estimate
- Lupus Erythematosus, Systemic -- complications
- Male
- Middle Aged
- Scleroderma, Systemic -- complications
- Sulfonamides -- administration & dosage
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.